Core Laboratories (NASDAQ: CLB) Stock On Most Active Line

Core Laboratories day trading at USD 28.34 per share, then rallying to 28.65 and closing at USD 26.74 per share. A net loss of -5.64% for the day. Long term pricing analysis shows the stock trading at 48.86% lower than it’s 52week high and -292.21% higher than the 52week low. The share volume traded for the day was 654K which was 0 times the 50 Day Average Volume.

Core Laboratories had a market cap of 1,188,772K as of 10th June 2020. The Earnings Per Share (EPS) for Q4 2019 is $-1.07.

Core Laboratories is a service provider of core and fluid analysis in the petroleum industry. Their specialties include basic rock properties, special core analysis, and PVT characterization of reservoir fluids.

Financial Results

Core Laboratories Reports the First Quarter Of Fiscal 2020.

  • COMPANY REVENUE OF $152.4 MILLION
  • GAAP EPS OF $(2.44); $0.31, EX-ITEMS
  • CORE GENERATES FCF FOR 74TH CONSECUTIVE QUARTER OF $19 MILLION
  • CORE REDUCES NET DEBT
  • COMPANY MAINTAINS OILFIELD SERVICE-LEADING ROIC OF 12.3%

Core Laboratories (10th June 2020): The Institutional Ownership as of today stood at 105.52% and the Total Value of Holdings (millions) is $ 1,341.

New Institutional Holders and other activity – As of today, the total number of shares held is 46,908,838 by 318 institutional holders.

LATEST NEWS:

8-June-2020:- $121.16 Million in Sales Expected for Core Laboratories (NYSE: CLB) This Quarter – Modern Readers

Equities analysts expect Core Laboratories (NYSE: CLB) to announce $121.16 million in sales for the current quarter, Zacks reports. Three analysts have made estimates for Core Laboratories’ earnings, with the highest sales estimate coming in at $125.00 million and the lowest estimate coming in at $115.70 million.

6-June-2020:- Core Laboratories (NYSE: CLB) Shares Purchased by CoreCommodity Management LLC

CoreCommodity Management LLC increased its stake in shares of Core Laboratories (NYSE: CLB) by 72.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 19,450 shares of the oil and gas company’s stock after acquiring an additional 8,157 shares during the period.

5-June-2020:- Core Laboratories (NYSE: CLB) Shares Purchased by Ensign Peak Advisors Inc

Ensign Peak Advisors Inc increased its holdings in shares of Core Laboratories (NYSE: CLB) by 229.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 141,106 shares of the oil and gas company’s stock after acquiring an additional 98,300 shares during the quarter.

Leave a Reply

Your email address will not be published. Required fields are marked *